PRESS RELEASE published on 04/11/2023 at 14:30, 3 years 5 months ago Patient Enrollment Surpasses 90% in Jaguar Health's Pivotal Phase 3 OnTarget Trial of Crofelemer for Cancer Therapy-Related Diarrhea
PRESS RELEASE published on 04/06/2023 at 14:30, 3 years 5 months ago Jaguar Health Provides Update on Monitoring Trading Activity to Identify Possible Illegal Short Selling
PRESS RELEASE published on 03/30/2023 at 14:30, 3 years 5 months ago Jaguar Animal Health Exhibiting at Veterinary Cancer Society Collaborative Conference for Canalevia-CA1, the Company's FDA Conditionally Approved Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs
PRESS RELEASE published on 03/27/2023 at 13:00, 3 years 5 months ago Jaguar Health Reports 2022 Financial Results - Prescription Revenues up 179% to $11.9 Million
PRESS RELEASE published on 03/24/2023 at 18:30, 3 years 5 months ago Jaguar Health Announces Time Change for March 27th Investor Webcast to 8:00 AM EDT
PRESS RELEASE published on 03/23/2023 at 13:30, 3 years 5 months ago Leading Cancer Patient Advocate Kelly Shanahan, M.D., Joins Jaguar Health's Scientific Advisory Board
PRESS RELEASE published on 03/21/2023 at 13:30, 3 years 5 months ago Jaguar Health to Hold Investor Webcast Monday, March 27th at 8:30 AM EDT Regarding Q4 2022 Financials & Corporate Updates
PRESS RELEASE published on 03/15/2023 at 13:30, 3 years 6 months ago Jaguar Health Celebrates U.N. International Day of Forests with Milestone of Providing Income to 20,000+ People Living in Tropical Rainforest Communities
PRESS RELEASE published on 03/13/2023 at 13:30, 3 years 6 months ago Jaguar Health Leveraging AI to Support Patient Access to Mytesi, the Company's FDA-Approved Prescription Drug
PRESS RELEASE published on 03/02/2023 at 14:30, 3 years 6 months ago Jaguar Health to Present at BioTrinity 2023 Conference’s R&D Spotlight on Rare Diseases
Published on 09/16/2026 at 16:55, 58 minutes ago CORRECTION FROM SOURCE: SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Published on 09/16/2026 at 15:00, 2 hours 53 minutes ago 2026 Canada's Top 40 Under 40(R) Honourees Announced
Published on 09/16/2026 at 14:00, 3 hours 53 minutes ago Ameriwest Awaits Bornite Core Assay Results and Provides Q3 2026 Corporate Update
Published on 09/16/2026 at 13:30, 4 hours 23 minutes ago Sterling Extends Core MEPS Copper Zone to 700m; Intersects 200m of 0.53% CuEq Including 102m of 0.81% CuEq
Published on 09/16/2026 at 13:23, 4 hours 30 minutes ago SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Published on 09/16/2026 at 17:35, 18 minutes ago M&G Credit Income Investment Trust plc: Net Asset Value(s)
Published on 09/16/2026 at 17:30, 23 minutes ago MP-14 ORIGIN BY JEFF KOONS - KOONS × HUBLOT: TWO UNIVERSES BUILT ON TRANSFORMATION
Published on 09/16/2026 at 17:20, 33 minutes ago HUBLOT - CLASSIC FUSION BALLOON DOG BY JEFF KOONS: TIME, INFLATED INTO ART
Published on 09/16/2026 at 17:15, 38 minutes ago Hong Kong’s 2026 Policy Address: A Strategic Vision for a Bright New Era
Published on 09/16/2026 at 17:45, 8 minutes ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 10 hours 53 minutes ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 23 hours 53 minutes ago Report on the Combined General Meeting of the 10th of September 2026
